Most Recent
Dr. Reddy’s slams Millennium’s injunction bid in cancer drug case
Intellectual Property 2018-08-23 5:41 pm By Miklos Bolza

An urgent injunction sought by US-based Millennium Pharmaceuticals to block generic drug maker Dr Reddy’s Laboratories from launching a cheap version of the breakthrough cancer drug Velcade has been panned as unnecessary.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

  1. Pages:
  3. 1
  4. 2
  5. 3
  6. 4
  7. 5
  8. 6
  9. 7
  10. 8
  11. 9